nh102
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 12, 2021 (NCT05015192)
Timeline
Indications
Studied for
Mechanism of action
- Serotonin 2a (5-HT2a) receptorANTAGONIST
HTR2A antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06842992 | Phase 2 | Dec 4, 2024 | Jiangsu Nhwa Pharmaceutical Co., Ltd. |
| NCT05015192 | Phase 1 | Aug 12, 2021 | Jiangsu Nhwa Pharmaceutical Co., Ltd., Jiao Tong University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Nhwa Pharmaceutical Co., Ltd. | For profit | 2 | 2 | 2 | 2021 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1